Blessedmestretchcocstrongスレ主:
Trading is halted because the company is not current in its required filings. The Securities and Exchange Commission has suspended trading in this stock. Trading is halted in conjunction with another exchange or market for regulatory reasons.
Gainers: •$ベル(VERU.US)$+25.8% (announces that in a Pre-EUA meeting held May 10 2022 FDA has agreed that the efficacy and safety data from the completed Phase 3 clinical study in hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome are sufficient to support the submission of a request for Emergency Use Authorization) •$デスクトップ メタル A(DM.US)$+15.8% (prices offering of $100 mln of 6.0% convertible se...
19
1
6
報告
我只想赚个买菜钱 :
NIO Pre-market UP 3.3%, before open market, immediately turned into RED. Only NIO able to do so. Haha.
Gainers: •$SailPoint Technologies(SAIL.US)$+30% (confirms agreement to be acquired by Thoma Bravo for $6.9 bln; stockholders to receive $65.25 per share in cash) •$ベル(VERU.US)$+28.9% (Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy) •$アフィメド(AFMD.US)$+12.9% (Presents Upda...
$チャイナ・コード・ブラッド(CO.US)$I am surprised that this company has not rocket up its price given the importance of cord blood to treat various sickness and stem cells transplant for various uses. it is a shame that the price is stagnant below 5 dollars. Earnings result will be on 1st March. Hope it will drive up the price to above 6 dollars or more. With advance technology in China, stem cells and cord blood should be lucrative business but not sure what went wrong in not driv...
チャイナ・コード・ブラッドに関するコメント
$スノウ レイク リソース(LITM.US)$ $スペル セラピューティックス(SPRO.US)$ $マクドナルド(MCD.US)$ $ジョンソン エンド ジョンソン(JNJ.US)$ $HHG キャピタル コーポレーション(HHGC.US)$ $MicroSectors U.S. Big Oil Index -3X Inverse Leveraged ETN(NRGD.US)$ $ドミノ ピザ(DPZ.US)$ $チャイナ・コード・ブラッド(CO.US)$ $エクイティ・レジデンシャル(EQR.US)$
• $Revlon(REV.US)$ +81% (Reliance mulling buyout of REV according to Economic Times)
• $ユナイテッド ステーツ スチール(X.US)$ +6.4% (issues upside EPS guidance),
• $エリントン・ファイナンシャル(EFC.US)$ +5% (reports book value per share)
• $オーロラ・モバイル(JG.US)$ +4.9% (receives RMB15 mln in special support funding from the Shenzhen Development and Reform Commission)
• $シティ トレンズ(CTRN.US)$ +4.4% (names new CFO)
• $ロク(ROKU.US)$ +4.2% (ROKU an...
• $ベル(VERU.US)$ +25.8% (announces that in a Pre-EUA meeting held May 10 2022 FDA has agreed that the efficacy and safety data from the completed Phase 3 clinical study in hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome are sufficient to support the submission of a request for Emergency Use Authorization)
• $デスクトップ メタル A(DM.US)$ +15.8% (prices offering of $100 mln of 6.0% convertible se...
• $SailPoint Technologies(SAIL.US)$ +30% (confirms agreement to be acquired by Thoma Bravo for $6.9 bln; stockholders to receive $65.25 per share in cash)
• $ベル(VERU.US)$ +28.9% (Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy)
• $アフィメド(AFMD.US)$ +12.9% (Presents Upda...
Earnings result will be on 1st March. Hope it will drive up the price to above 6 dollars or more. With advance technology in China, stem cells and cord blood should be lucrative business but not sure what went wrong in not driv...
まだコメントはありません